Company registration number 16053667 (England and Wales)
EMENTINE MEDICAL LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE PERIOD ENDED 31 OCTOBER 2025
PAGES FOR FILING WITH REGISTRAR
Affinia
The Octagon Suite E2
2nd Floor Middleborough
Colchester
Essex
CO1 1TG
EMENTINE MEDICAL LIMITED
BALANCE SHEET
AS AT
31 OCTOBER 2025
31 October 2025
- 1 -
2025
£
£
Current assets
136,875
Creditors: amounts falling due within one year
(38,394)
Net current assets
98,481
Net assets
98,481
Capital and reserves
98,481
Notes to the financial statements
1
Reporting period

The reporting period length of the financial statements is prepared over an extended period of over 12 months where this is the first set since incorporation. Therefore the results will not be wholly comparable to future periods.

2
Employees

The average number of persons, including directors, employed by the company during the period wa s as follows:

2025
Number
Employees
2

Ementine Medical Limited is a private company limited by shares incorporated in England and Wales. The registered office is The Octagon, Suite E2, 2nd Floor, Middleborough, Essex, CO1 1TG.

For the period ended 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476.

These financial statements have been prepared in accordance with the micro-entity provisions and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime', and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

EMENTINE MEDICAL LIMITED
BALANCE SHEET (CONTINUED)
AS AT
31 OCTOBER 2025
31 October 2025
- 2 -
The financial statements were approved by the board of directors and authorised for issue on 16 July 2026 and are signed on its behalf by:
Mr W Wynn-Jones
Director
Company registration number 16053667 (England and Wales)
2025-10-31 2024-11-01 false false CCH Software CCH Accounts Production 2026.100 No description of principal activity Mr W Wynn-Jones Ms A James false 16053667 2024-11-01 2025-10-31 16053667 2025-10-31 16053667 core:CurrentFinancialInstruments core:WithinOneYear 2025-10-31 16053667 bus:Director1 2024-11-01 2025-10-31 16053667 bus:PrivateLimitedCompanyLtd 2024-11-01 2025-10-31 16053667 bus:SmallCompaniesRegimeForAccounts 2024-11-01 2025-10-31 16053667 bus:Micro-entities 2024-11-01 2025-10-31 16053667 bus:AuditExemptWithAccountantsReport 2024-11-01 2025-10-31 16053667 bus:Director2 2024-11-01 2025-10-31 16053667 bus:FullAccounts 2024-11-01 2025-10-31 xbrli:pure xbrli:shares iso4217:GBP